| 中文关键词: 膀胱癌 膀胱灌注 化疗 免疫治疗 |
| 英文关键词:bladder cancer intravesical therapy chemotherapy immunotherapy |
| 基金项目:卫生部科研基金资助项目(WKJ2013-2-005)；浙江省公益性技术应用研究项目( 2014C33125) |
|
| 摘要点击次数: 2463 |
| 全文下载次数: 448 |
| 中文摘要: |
| 摘 要：大部分膀胱癌为非肌层浸润性癌，其标准治疗方法为经尿道膀胱肿瘤电切术，但术后复发率高，一部分患者会发展为肌层浸润性癌，对于具有复发和进展危险因素的患者采用膀胱内灌注免疫制剂或化疗药物治疗，膀胱内灌注标准药物无效的患者采用根治性膀胱全切术，新的治疗方法正在进行临床试验，如果有效，将提高非肌层浸润性膀胱癌的治疗效果。 |
| 英文摘要: |
| Abstract：The majority of bladder cancer diagnoses are non muscle invasive. Transurethral resection of the bladder tumor is the current standard therapy for non muscle invasive bladder cancer. However，many patients have recurrent cancer and some will progress to muscle invasive disease. Intravesical immunotherapy or chemotherapy are used to patients with risks of recurrence and progression. Patients with no response to standard intravesical therapeutic agents will undergo radical cystectomy. Novel strategies currently being investigated，if effective，would improve the outcome of non muscle invasive bladder cancer. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |
